{"id":"https://openalex.org/W2108324409","doi":"https://doi.org/10.1016/j.jpainsymman.2006.07.006","title":"Efficacy of Pregabalin in the Management of Cetuximab-Related Itch","display_name":"Efficacy of Pregabalin in the Management of Cetuximab-Related Itch","publication_year":2006,"publication_date":"2006-11-01","ids":{"openalex":"https://openalex.org/W2108324409","doi":"https://doi.org/10.1016/j.jpainsymman.2006.07.006","mag":"2108324409","pmid":"https://pubmed.ncbi.nlm.nih.gov/17085262"},"language":"en","primary_location":{"id":"doi:10.1016/j.jpainsymman.2006.07.006","doi":"https://doi.org/10.1016/j.jpainsymman.2006.07.006","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jpainsymman.2006.07.006","pdf_url":"http://www.jpsmjournal.com/article/S0885392406005203/pdf","source":{"id":"https://openalex.org/S135898356","display_name":"Journal of Pain and Symptom Management","issn_l":"0885-3924","issn":["0885-3924","1873-6513"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pain and Symptom Management","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"http://www.jpsmjournal.com/article/S0885392406005203/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5090705680","display_name":"Giampiero Porzio","orcid":"https://orcid.org/0000-0002-9875-9220","observed_orcids":["https://orcid.org/0000-0002-9875-9220"]},"institutions":[{"id":"https://openalex.org/I26415053","display_name":"University of L'Aquila","ror":"https://ror.org/01j9p1r26","country_code":"IT","type":"education","lineage":["https://openalex.org/I26415053"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Giampiero Porzio","raw_affiliation_strings":["Supportive Care Task Force, Medical Oncology Department, University of L'Aquila, L'Aquila, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Supportive Care Task Force, Medical Oncology Department, University of L'Aquila, L'Aquila, Italy","institution_ids":["https://openalex.org/I26415053"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021379718","display_name":"Federica Aielli","orcid":"https://orcid.org/0000-0003-2785-0702","observed_orcids":["https://orcid.org/0000-0003-2785-0702"]},"institutions":[{"id":"https://openalex.org/I26415053","display_name":"University of L'Aquila","ror":"https://ror.org/01j9p1r26","country_code":"IT","type":"education","lineage":["https://openalex.org/I26415053"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Federica Aielli","raw_affiliation_strings":["Supportive Care Task Force, Medical Oncology Department, University of L'Aquila, L'Aquila, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Supportive Care Task Force, Medical Oncology Department, University of L'Aquila, L'Aquila, Italy","institution_ids":["https://openalex.org/I26415053"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010067465","display_name":"Lucilla Verna","orcid":"https://orcid.org/0000-0002-2046-3980","observed_orcids":["https://orcid.org/0000-0002-2046-3980"]},"institutions":[{"id":"https://openalex.org/I26415053","display_name":"University of L'Aquila","ror":"https://ror.org/01j9p1r26","country_code":"IT","type":"education","lineage":["https://openalex.org/I26415053"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Lucilla Verna","raw_affiliation_strings":["Supportive Care Task Force, Medical Oncology Department, University of L'Aquila, L'Aquila, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Supportive Care Task Force, Medical Oncology Department, University of L'Aquila, L'Aquila, Italy","institution_ids":["https://openalex.org/I26415053"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033310482","display_name":"Claudio Porto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210098685","display_name":"San Salvatore Hospital","ror":"https://ror.org/0112t7451","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210098685"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Claudio Porto","raw_affiliation_strings":["Neurophysiopathology Unit, San Salvatore Hospital, L'Aquila, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurophysiopathology Unit, San Salvatore Hospital, L'Aquila, Italy","institution_ids":["https://openalex.org/I4210098685"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004581470","display_name":"Marianna Tudini","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I26415053","display_name":"University of L'Aquila","ror":"https://ror.org/01j9p1r26","country_code":"IT","type":"education","lineage":["https://openalex.org/I26415053"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Marianna Tudini","raw_affiliation_strings":["Medical Oncology Department, University of L'Aquila, L'Aquila, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Department, University of L'Aquila, L'Aquila, Italy","institution_ids":["https://openalex.org/I26415053"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027420799","display_name":"Katia Cannita","orcid":"https://orcid.org/0000-0002-9409-1171","observed_orcids":["https://orcid.org/0000-0002-9409-1171"]},"institutions":[{"id":"https://openalex.org/I26415053","display_name":"University of L'Aquila","ror":"https://ror.org/01j9p1r26","country_code":"IT","type":"education","lineage":["https://openalex.org/I26415053"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Katia Cannita","raw_affiliation_strings":["Medical Oncology Department, University of L'Aquila, L'Aquila, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Department, University of L'Aquila, L'Aquila, Italy","institution_ids":["https://openalex.org/I26415053"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5020344479","display_name":"Corrado Ficorella","orcid":"https://orcid.org/0000-0003-0960-7127","observed_orcids":["https://orcid.org/0000-0003-0960-7127"]},"institutions":[{"id":"https://openalex.org/I26415053","display_name":"University of L'Aquila","ror":"https://ror.org/01j9p1r26","country_code":"IT","type":"education","lineage":["https://openalex.org/I26415053"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Corrado Ficorella","raw_affiliation_strings":["Medical Oncology Department, University of L'Aquila, L'Aquila, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Department, University of L'Aquila, L'Aquila, Italy","institution_ids":["https://openalex.org/I26415053"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4760,"currency":"USD","value_usd":4760},"apc_paid":null,"fwci":3.4324,"has_fulltext":false,"cited_by_count":53,"citation_normalized_percentile":{"value":0.91948725,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"32","issue":"5","first_page":"397","last_page":"398"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12937","display_name":"Chemotherapy-related skin toxicity","score":0.9829000234603882,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12937","display_name":"Chemotherapy-related skin toxicity","score":0.9829000234603882,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.004900000058114529,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.004800000227987766,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pregabalin","display_name":"pregabalin","score":0.9570000171661377},{"id":"https://openalex.org/keywords/cetuximab","display_name":"cetuximab","score":0.9950000047683716},{"id":"https://openalex.org/keywords/drug-induced-pruritus","display_name":"drug-induced pruritus","score":0.753000020980835},{"id":"https://openalex.org/keywords/skin-reactions","display_name":"skin reactions","score":0.5789999961853027},{"id":"https://openalex.org/keywords/egfr-inhibitors","display_name":"EGFR inhibitors","score":0.921999990940094},{"id":"https://openalex.org/keywords/acneiform-eruption","display_name":"acneiform eruption","score":0.6809999942779541},{"id":"https://openalex.org/keywords/dry-skin","display_name":"dry skin","score":0.8209999799728394},{"id":"https://openalex.org/keywords/atopic-dermatitis","display_name":"atopic dermatitis","score":0.7739999890327454},{"id":"https://openalex.org/keywords/metastatic-colorectal-cancer","display_name":"metastatic colorectal cancer","score":0.843999981880188},{"id":"https://openalex.org/keywords/antipruritic-treatment","display_name":"antipruritic therapy","score":0.7839999794960022}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8988519906997681},{"id":"https://openalex.org/C2779998722","wikidata":"https://www.wikidata.org/wiki/Q420296","display_name":"Cetuximab","level":4,"score":0.8822174668312073},{"id":"https://openalex.org/C2778087573","wikidata":"https://www.wikidata.org/wiki/Q418369","display_name":"Erlotinib","level":4,"score":0.7519946098327637},{"id":"https://openalex.org/C2777506169","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"EGFR inhibitors","level":4,"score":0.674271285533905},{"id":"https://openalex.org/C2778570526","wikidata":"https://www.wikidata.org/wiki/Q653197","display_name":"Rash","level":2,"score":0.6557796001434326},{"id":"https://openalex.org/C2780580887","wikidata":"https://www.wikidata.org/wiki/Q417824","display_name":"Gefitinib","level":4,"score":0.6009137630462646},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.5854585766792297},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.5479297041893005},{"id":"https://openalex.org/C2778332735","wikidata":"https://www.wikidata.org/wiki/Q417775","display_name":"Panitumumab","level":5,"score":0.5038239359855652},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4354168772697449},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.4278486371040344},{"id":"https://openalex.org/C2778169587","wikidata":"https://www.wikidata.org/wiki/Q3896379","display_name":"Paronychia","level":2,"score":0.41040685772895813},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4074828326702118},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4071660339832306},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3874010443687439}],"mesh":[{"descriptor_ui":"D000068818","descriptor_name":"Cetuximab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000069583","descriptor_name":"Pregabalin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000700","descriptor_name":"Analgesics","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D005680","descriptor_name":"gamma-Aminobutyric Acid","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D005680","descriptor_name":"gamma-Aminobutyric Acid","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011537","descriptor_name":"Pruritus","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D011537","descriptor_name":"Pruritus","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1016/j.jpainsymman.2006.07.006","doi":"https://doi.org/10.1016/j.jpainsymman.2006.07.006","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jpainsymman.2006.07.006","pdf_url":"http://www.jpsmjournal.com/article/S0885392406005203/pdf","source":{"id":"https://openalex.org/S135898356","display_name":"Journal of Pain and Symptom Management","issn_l":"0885-3924","issn":["0885-3924","1873-6513"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pain and Symptom Management","raw_type":"journal-article"},{"id":"pmid:17085262","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17085262","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of pain and symptom management","raw_type":"Case Reports"},{"id":"pmh:oai:ricerca.univaq.it:11697/10404","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/11697/10404","pdf_url":null,"source":{"id":"https://openalex.org/S7407055225","display_name":"Archivio Istituzionale della Ricerca - Universit\u00e0 degli Studi dell Aquila","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1016/j.jpainsymman.2006.07.006","doi":"https://doi.org/10.1016/j.jpainsymman.2006.07.006","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jpainsymman.2006.07.006","pdf_url":"http://www.jpsmjournal.com/article/S0885392406005203/pdf","source":{"id":"https://openalex.org/S135898356","display_name":"Journal of Pain and Symptom Management","issn_l":"0885-3924","issn":["0885-3924","1873-6513"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pain and Symptom Management","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":10,"referenced_works":["https://openalex.org/W1959598232","https://openalex.org/W2014759758","https://openalex.org/W2031004040","https://openalex.org/W2073779657","https://openalex.org/W2077643770","https://openalex.org/W2118613778","https://openalex.org/W2151979638","https://openalex.org/W2155118474","https://openalex.org/W2163592822","https://openalex.org/W2428442425"],"related_works":["https://openalex.org/W1930879179","https://openalex.org/W2071772209","https://openalex.org/W2126948867","https://openalex.org/W2083158206","https://openalex.org/W2101100211","https://openalex.org/W2070524877","https://openalex.org/W2341086420","https://openalex.org/W2777676121","https://openalex.org/W1935726921","https://openalex.org/W2100868213"],"abstract_inverted_index":null,"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":4},{"year":2013,"cited_by_count":8},{"year":2012,"cited_by_count":7}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}